Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2007-05-22
2007-05-22
Fay, Zohreh (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S557000, C514S912000, C514S913000
Reexamination Certificate
active
09866961
ABSTRACT:
The present invention relates to pharmaceutical compositions and methods for treating a retinal disorder or glaucoma using NAALADase inhibitors.
REFERENCES:
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5824662 (1998-10-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5977090 (1999-11-01), Slusher et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 5985855 (1999-11-01), Slusher et al.
patent: 6004946 (1999-12-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6028216 (2000-02-01), Morales et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6071965 (2000-06-01), Jackson et al.
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6159958 (2000-12-01), Meyerhoff et al.
patent: 6228888 (2001-05-01), Slusher
patent: 6265609 (2001-07-01), Jackson et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: WO 99/08521 (1998-08-01), None
patent: WO 99/33849 (1999-07-01), None
patent: WO 00/01668 (2000-01-01), None
patent: WO 01/14390 (2001-03-01), None
Jackson et al., “Design Synthesis and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated α-Linked Acidic Dipeptidase”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 39, No. 2, 1996, pp. 619-622.
Ueda et al., Jun, “Experimental Glaucoma Model in the Rat Induced by Laser Travecular Photocoagulation After an Intracameral Injection of India Ink”, Japan Journal Ophthalmology, vol. 42, 1998, pp. 337-344.
Neufeld et al., A.H., “Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma”, Proc. Natl. Acad. Sci., vol. 96, Aug. 1999, pp. 9944-9948.
Morrison et al., J.C., “A Rat Model of Chronic Pressure-induced Optic Nerve Damage”, Exp. Eye Res., vol. 64, No. 1, Jan. 1997, pp. 85-96.
Morrison et al., J.C., “Glaucoma Drops Control Intraocular Pressure and Protect Optic Nerves in a Rat Model of Glaucoma”, Investigative Ophthalmology & Visual Science, vol. 39, No. 3, Mar. 1998, pp. 526-531.
Laver et al., N.M., “Novel Procedures for Isolating Intact Retinal Vascular Beds From Diabetic Humans and Animal Models”, Investigative Ophthalmology & Visual Science, vol. 34, No. 6, May 1993, pp. 2097-2104.
Gundersen et al., H.J.G., “Optimizing sampling efficiency of stereological studies in biology: or ‘Do more less well!’”, Journal of Microscopy, vol. 121, Pt. 1, Jan. 1981, pp. 65-73.
Harada et al., C., “N-acetylated-α-linked-acidic dipeptidase inhibitor has a neuroprotective effect on mouse retinal ganglion cells after pressure-induced ischemia”, Neuroscience Letters, vol. 286, 2000, pp. 1-3.
Quigley et al., D.J., “Naaladase Inhibitors Prevent Retinal Ganglion Cell Death In Experimental Glaucoma and After Optic Nerve Transection In The Rat”, Glaucoma Service, Wilmer Institute, Johns Hopkins School of Medicine.
Kuwabara et al., T., “Studies of Retinal Vascular Patterns”, Achives of Ophthalmology, vol. 64, No. 6, Dec. 1960, pp. 904-911.
Collman et al., J.P., “Dioxygen Binding in Iron and Cobalt Picnic Basket Porphyrins”, J. Am. Chem. Soc., vol. 116, No. 14, 1994, pp. 6245-6251.
Cuthbertson et al., R.A., “Anatomy of the Mouse Retina. Endothelial Cell-Pericyte Ratio and Capillary Distribution”, Investigative Ophthalmology & Visual Science, vol. 27, No. 11, Nov. 1986, pp. 1659-1664.
Bendayan, M., “Protein A-Gold Electron Microscopic Immunocytochemistry: Methods, Applications, and Limitations”, Journal of Electron Microscopy Technique, vol. 1, 1984, pp. 243-270.
Slusher Barbara S.
Wozniak Krystyna
Arnold & Porter LLP
Fay Zohreh
Guilford Pharmaceuticals Inc.
LandOfFree
Naaladase inhibitors for treating retinal disorders and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naaladase inhibitors for treating retinal disorders and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naaladase inhibitors for treating retinal disorders and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3730028